National Foundation for Cancer Research collaborates with Onconetics Pharmaceuticals, Inc.
Onconetics Pharmaceuticals, inc. announces its admittance into San Francisco-based biotech accelerator IndieBio with funding from SOSV.
Global Action Platform Summit
Onconetics cofounders meet in Nashville, TN for the annual GAP summit with world leaders in Health and Innovation.
Miami Family Fund Conference
As VIP guests of the National Foundation for Cancer Research, Onconetics attends the Deal Flow Family Fund Summit in Miami, FL. The summit is the largest gathering of family funds in the US.
Proof of Concept Acheived
Onconetics demonstrats selective killing between healthy breast cells and breast cancer cells as the culmination of five months’ work at IndieBio.
California Life Science Association
Onconetics cofounder and COO Gabe Hithcock presents Onconetics’ pioneering gene therapy approach at IndieBio’s Demo Day to hundreds of investors.
Future of Cancer Therapeutics Forum
Onconetics cofounder and CEO Luke Gruenert is invited to speak as a panelist for CalTech’s 2018 Future of Cancer Therapeutics Forum, joining esteemed guests to discuss the direction of healthcare in the coming years.